Page last updated: 2024-11-03

risperidone and Choreoathetosis Self-Mutilation Hyperuricemia Syndrome

risperidone has been researched along with Choreoathetosis Self-Mutilation Hyperuricemia Syndrome in 3 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, SM2
Rice, SN1
Freeman, JN1
Davis, WM1
Saito, Y1
Yamashita, S1
Kaneko, K1
Kimura, S1
Osawa, M1

Other Studies

3 other studies available for risperidone and Choreoathetosis Self-Mutilation Hyperuricemia Syndrome

ArticleYear
Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient.
    Progress in neuro-psychopharmacology & biological psychiatry, 1996, Volume: 20, Issue:5

    Topics: Adult; Dopamine Antagonists; Humans; Lesch-Nyhan Syndrome; Male; Risperidone; Self Mutilation

1996
Evaluation of risperidone in the neonatal 6-hydroxydopamine model of Lesch-Nyhan syndrome.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 59, Issue:2

    Topics: Animals; Animals, Newborn; Behavior, Animal; Benzazepines; Disease Models, Animal; Dopamine Agents;

1998
[The effect of risperidone on the self-mutilation of Lesch-Nyhan syndrome].
    No to hattatsu = Brain and development, 2001, Volume: 33, Issue:3

    Topics: Child; Dopamine Antagonists; Humans; Lesch-Nyhan Syndrome; Male; Risperidone; Self Mutilation

2001